Clinical Trial Update: Fenoldopam and Ketanserin for Acute Kidney Failure Prevention After Cardiac Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating fenoldopam and ketanserin to prevent acute kidney injury after cardiac surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Fenoldopam (fenoldopam)
• Ketanserin (ketanserin)

Snippet

Sponsor: Medical University of Gdansk | Conditions: Acute Renal Failure | Phase 3 | Status: TERMINATED